Compare · EUDA vs LFST
EUDA vs LFST
Side-by-side comparison of EUDA Health Holdings Limited (EUDA) and LifeStance Health Group Inc. (LFST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EUDA and LFST operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.49B, about 132.7x EUDA ($33.8M).
- Over the past year, EUDA is down 76.2% and LFST is up 173.8% - LFST leads by 250.0 points.
- LFST has been more active in the news (13 items in the past 4 weeks vs 2 for EUDA).
- LFST has more recent analyst coverage (17 ratings vs 0 for EUDA).
- Company
- EUDA Health Holdings Limited
- LifeStance Health Group Inc.
- Price
- $15.02-16.60%
- $11.57+2.39%
- Market cap
- $33.8M
- $4.49B
- 1M return
- +0.00%
- +34.07%
- 1Y return
- -76.16%
- +173.85%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 2
- 13
- Recent ratings
- 0
- 17
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Latest EUDA
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited
- Amendment: SEC Form F-3/A filed by EUDA Health Holdings Limited
- SEC Form 424B5 filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- Amendment: SEC Form SCHEDULE 13G/A filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- SEC Form 6-K filed by EUDA Health Holdings Limited
- EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
- EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
- SEC Form F-3 filed by EUDA Health Holdings Limited
Latest LFST
- LifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026
- Director Burdick Kenneth A was granted 45,495 shares, increasing direct ownership by 1% to 3,470,810 units (SEC Form 4)
- Director Palmer Eric P was granted 17,746 shares, increasing direct ownership by 25% to 89,174 units (SEC Form 4)
- Director Bessler Robert was granted 17,746 shares, increasing direct ownership by 31% to 75,365 units (SEC Form 4)
- Director Personette Sarah was granted 17,746 shares, increasing direct ownership by 24% to 92,512 units (SEC Form 4)
- Director Deluca Teresa was granted 17,746 shares, increasing direct ownership by 17% to 125,034 units (SEC Form 4)
- Director Justice Thurman was granted 35,492 shares (SEC Form 4)
- Director Goltermann Lori was granted 35,492 shares (SEC Form 4)
- SEC Form 3 filed by new insider Goltermann Lori
- SEC Form 3 filed by new insider Justice Thurman